Manipal Health Enterprises (NSE:MANIPALHOS) Notes Receivable: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MANIPALHOS Manipal Health Enterprises Ltd NSE:MANIPALHOS
13 GF Score
Price ₹771.65
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises Notes Receivable?

Manipal Health Enterprises NSE:MANIPALHOS -3.30% 13 Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Manipal Health Enterprises's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0 Mil.

Manipal Health Enterprises Notes Receivable Related Terms

Manipal Health Enterprises Notes Receivable Historical Data

* Premium members only.

The historical data trend for Manipal Health Enterprises's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises Notes Receivable Chart

Manipal Health Enterprises Annual Data
Trend Mar24 Mar25 Mar26
Notes Receivable
0.00 0.00 0.00

Manipal Health Enterprises Semi-Annual Data
Mar24 Mar25 Mar26
Notes Receivable 0.00 0.00 0.00
NSE:MANIPALHOS
13GF Score
Manipal Health Enterprises Ltd NSE:MANIPALHOS
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Manipal Health Enterprises (NSE:MANIPALHOS) has a Notes Receivable of ₹0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Manipal Health Enterprises and its competitors.
Is Manipal Health Enterprises' Notes Receivable too high?
Manipal Health Enterprises' current Notes Receivable is ₹0 Mil. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Notes Receivable compare to HCA and THC?
Manipal Health Enterprises' Notes Receivable of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Manipal Health Enterprises and its competitors. Manipal Health Enterprises's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current Notes Receivable of ₹0 Mil. The current Notes Receivable is ₹0 Mil. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manipal Health Enterprises Business Description

Other Exchanges 544847:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for NSE:MANIPALHOS

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.65
Price